We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Hogan Lovells Expands New York Office with Corporate partner Adam Golden

10 February 2014

NEW YORK 10 February 2014 – Hogan Lovells today announced the further expansion of its New York office with the addition of Corporate partner Adam Golden. This adds to other strategic additions to the office in recent months.

“Adam’s arrival is yet another success as we continue to expand our corporate practice in our New York office,” said Stuart Stein, global Co-head of the Hogan Lovells Corporate Practice Group. “Our growth in the New York office over the past several years with leading corporate partners like Adam Golden further validates the platform we offer to our clients with a combination of the highest quality and globally integrated practice.”

The arrival of Golden complements the recent additions of International Arbitration and Litigation partner Oliver J. Armas, Products Liability and Life Sciences partner Phoebe Wilkinson, and Corporate M&A partner Michael Gilligan.

“The significant growth of the New York office over the past few years has given us a strong team to provide the highest quality service to our clientele in the US and throughout the world,” said New York office Managing Partner Dennis Tracey. “Adam’s addition reinforces our robust corporate presence in New York, and further expands our capabilities to serve clients, particularly in the life sciences sector.”

Golden joined Hogan Lovells from Kaye Scholer. Golden has practiced law in New York his entire career and served as Co-Chair of his former firm’s Corporate Department. His practice has focused on mergers and acquisitions, securities offerings, intellectual property licenses, joint ventures, and other corporate partnering transactions. In the course of his career, Golden has represented companies in the pharmaceutical and biotechnology, private equity, infrastructure, chemicals, consumer products, technology, software, healthcare services, medical devices, defense, finance, and alternative asset management industries. Golden received his J.D. from the New York University School of Law and received his A.B. from Princeton University.

“I was particularly drawn to Hogan Lovells’ global M&A platform, as well as its cross-departmental expertise in the life sciences sector,” said Golden. “These capabilities will allow me, together with the Hogan Lovells team, to significantly expand the scope of deals I can engage in, as well as further develop my practice internationally.”

Loading data